PRCT insider buying & filings

← All candidates

PRCTPROCEPT BioRobotics Corp

NasdaqGM · Healthcare · $1.10B

$19.44

+0.73% today

One insider buy in the last year — $498.3K in all.
Nothing in the last fortnight.

Last Form 4 Sep 10 · scanned 5m ago

Price · 1Y · daily● 1 buy● 3 sells◆ 1 8-K

▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

▸ Included with Pro →

Market cap

$1.10B

Float

55.8M

98% public

Short % float

Pro

Price / profit

—

not yet profitable

Price / future profit

—

Price / sales

3.3

The buyers

▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions

Director

Moll Frederic H

Bought $785.1K on Aug 13 — 20,000 sh @ $39.26, held direct, 2.3% of their stake.

First Form 4 on file

no positions we can measure against the market — the record starts here

President, CEO

Wood Larry L

Bought $498.3K on Aug 7 — 23,900 sh @ $20.85, held indirect, 100% of their stake.

First Form 4 on file

no positions we can measure against the market — the record starts here

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Sep 10SELLNouri AlalehEVP, CLO, CORP. SEC.direct297 @ $20.95$6.2K

Sep 10SELLTemplin Barry LEVP, Chief Technology Officerdirect373 @ $20.95$7.8K

Sep 10SELLWaters KevinEVP, CFOdirect373 @ $20.95$7.8K

Aug 14GRANTNouri AlalehEVP, CLO, CORP. SEC.direct22,965 sh—

Aug 10BUYWood Larry LPresident, CEO+100%indirect23,900 @ $20.85$498.3K

45 more transactions on Pro →

Context

Wall St

$21.64 avg target

+11.3% vs today · 11 analysts · consensus Hold

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

Earnings · EPS vs forecast

3 of 5 quarters beat

Q2 '26−$0.47 act−$0.02

Q1 '26−$0.56 act+$0.00

Q4 '25−$0.53 act−$0.21

Q3 '25−$0.38 act+$0.04

Coverage

Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth PotentialInsider Monkey · 06-30 Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right NowInsider Monkey · 06-25 Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?Insider Monkey · 06-19 PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's ChangedSimply Wall St. · 06-01

The file stays open

50 filings on record.
The next one will be too.

All candidates

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice

Moll Frederic H

Wood Larry L

50 filings on record.The next one will be too.

50 filings on record.
The next one will be too.